サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316681

細胞分析市場：製品、プロセス、エンドユーザー別-2023～2030年の世界予測

Cell Analysis Market by Product, Process, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
細胞分析市場：製品、プロセス、エンドユーザー別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞分析の世界市場は、2023年に221億4,000万米ドル、CAGR 9.56%で大幅な成長が予測され、2030年には420億3,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の細胞分析市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.細胞分析の世界市場規模および予測は？

2.予測期間中、世界の細胞分析市場を形成するCOVID-19の阻害要因と影響は？

3.細胞分析の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.細胞分析の世界市場における競争戦略は？

5.細胞分析の世界市場における技術動向と規制の枠組みは？

6.細胞分析の世界市場における主要ベンダーの市場シェアは？

7.細胞分析の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患や感染症の発生率の増加
      • 先進技術の製品や診断機関の出現
      • ライフサイエンス分野への政府投資とバイオ医薬品およびバイオテクノロジー産業の急速な拡大
    • 抑制要因
      • 熟練した専門家の確保が限られている
    • 機会
      • 研究開発や新製品開発における連携活動
      • 個別化医療における細胞分析の応用
    • 課題
      • 複雑で時間のかかる規制ガイドライン
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ
    • 分析ツールの導入

第6章 細胞分析市場：製品別

  • イントロダクション
  • セルカウンター
  • 細胞マイクロアレイ
  • フローサイトメトリー製品
  • ハイコンテンツスクリーニングシステム
  • 顕微鏡
  • QPCR製品
  • 分光光度計

第7章 細胞分析市場：プロセス別

  • イントロダクション
  • 細胞計数と品質管理
  • 細胞の識別
  • 細胞相互作用
  • 細胞増殖
  • 細胞シグナル伝達経路またはシグナル伝達
  • 細胞構造の研究
  • 細胞生存率
  • 単一細胞解析
  • ターゲットの特定と検証

第8章 細胞分析市場：エンドユーザー別

  • イントロダクション
  • 細胞培養コレクションのリポジトリ
  • 受託研究機関
  • 病院と診断研究所
  • 製薬およびバイオテクノロジー企業
  • 研究機関

第9章 南北アメリカの細胞分析市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の細胞分析市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの細胞分析市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CELL ANALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. CELL ANALYSIS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CELL ANALYSIS MARKET SIZE, BY PROCESS, 2022 VS 2030 (%)
  • FIGURE 6. CELL ANALYSIS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. CELL ANALYSIS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. CELL ANALYSIS MARKET DYNAMICS
  • FIGURE 9. CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. CELL ANALYSIS MARKET SIZE, BY PROCESS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CELL ANALYSIS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CELL ANALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CELL ANALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CELL ANALYSIS MARKET SIZE, BY CELL COUNTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. CELL ANALYSIS MARKET SIZE, BY CELL MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL ANALYSIS MARKET SIZE, BY FLOW CYTOMETRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CELL ANALYSIS MARKET SIZE, BY HIGH-CONTENT SCREENING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL ANALYSIS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL ANALYSIS MARKET SIZE, BY QPCR PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CELL ANALYSIS MARKET SIZE, BY SPECTROPHOTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 13. CELL ANALYSIS MARKET SIZE, BY CELL COUNTING & QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CELL ANALYSIS MARKET SIZE, BY CELL IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CELL ANALYSIS MARKET SIZE, BY CELL INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL ANALYSIS MARKET SIZE, BY CELL PROLIFERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CELL ANALYSIS MARKET SIZE, BY CELL SIGNALING PATHWAY OR SIGNAL TRANSDUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL ANALYSIS MARKET SIZE, BY CELL STRUCTURE STUDY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL ANALYSIS MARKET SIZE, BY CELL VIABILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CELL ANALYSIS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. CELL ANALYSIS MARKET SIZE, BY TARGET IDENTIFICATION & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CELL ANALYSIS MARKET SIZE, BY CELL CULTURE COLLECTION REPOSITORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CELL ANALYSIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CELL ANALYSIS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. CELL ANALYSIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. CELL ANALYSIS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CELL ANALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 75. SINGAPORE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. SOUTH KOREA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 81. TAIWAN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 84. THAILAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 87. VIETNAM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 94. DENMARK CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 97. EGYPT CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. FINLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. FRANCE CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 106. GERMANY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 109. ISRAEL CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 112. ITALY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 115. NETHERLANDS CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. NIGERIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 121. NORWAY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. POLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 127. QATAR CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 130. RUSSIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 133. SAUDI ARABIA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH AFRICA CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. SPAIN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 142. SWEDEN CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 145. SWITZERLAND CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 148. TURKEY CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED ARAB EMIRATES CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED KINGDOM CELL ANALYSIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. CELL ANALYSIS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 156. CELL ANALYSIS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 157. CELL ANALYSIS MARKET LICENSE & PRICING
目次
Product Code: MRR-431F213C90C8

The Global Cell Analysis Market is forecasted to grow significantly, with a projected USD 22.14 billion in 2023 at a CAGR of 9.56% and expected to reach a staggering USD 42.03 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell Analysis Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell Analysis Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Cell Counters, Cell Microarrays, Flow Cytometry Products, High-Content Screening Systems, Microscopes, QPCR Products, and Spectrophotometers. The Cell Microarrays is projected to witness significant market share during forecast period.

Based on Process, market is studied across Cell Counting & Quality Control, Cell Identification, Cell Interaction, Cell Proliferation, Cell Signaling Pathway or Signal Transduction, Cell Structure Study, Cell Viability, Single-Cell Analysis, and Target Identification & Validation. The Cell Interaction is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Cell Culture Collection Repositories, Contract Research Organizations, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Research Institutes. The Pharmaceutical & Biotechnology Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell Analysis Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell Analysis Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Analysis Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Analysis Market?

4. What is the competitive strategic window for opportunities in the Global Cell Analysis Market?

5. What are the technology trends and regulatory frameworks in the Global Cell Analysis Market?

6. What is the market share of the leading vendors in the Global Cell Analysis Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell Analysis Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Analysis Market, by Product, 2022 vs 2030
  • 4.3. Cell Analysis Market, by Process, 2022 vs 2030
  • 4.4. Cell Analysis Market, by End-User, 2022 vs 2030
  • 4.5. Cell Analysis Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic and infectious diseases
      • 5.1.1.2. Introduction of technologically advanced products and diagnostic laboratories
      • 5.1.1.3. Government investments in life sciences sector and rapid expansion of the biopharmaceutical & biotechnological industry
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaboration activities for R&D and new product development
      • 5.1.3.2. Applications of cell analysis in personalized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Complex & time-consuming regulatory guidelines
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization
    • 5.9.1. Adoption of Analytical Tools

6. Cell Analysis Market, by Product

  • 6.1. Introduction
  • 6.2. Cell Counters
  • 6.3. Cell Microarrays
  • 6.4. Flow Cytometry Products
  • 6.5. High-Content Screening Systems
  • 6.6. Microscopes
  • 6.7. QPCR Products
  • 6.8. Spectrophotometers

7. Cell Analysis Market, by Process

  • 7.1. Introduction
  • 7.2. Cell Counting & Quality Control
  • 7.3. Cell Identification
  • 7.4. Cell Interaction
  • 7.5. Cell Proliferation
  • 7.6. Cell Signaling Pathway or Signal Transduction
  • 7.7. Cell Structure Study
  • 7.8. Cell Viability
  • 7.9. Single-Cell Analysis
  • 7.10. Target Identification & Validation

8. Cell Analysis Market, by End-User

  • 8.1. Introduction
  • 8.2. Cell Culture Collection Repositories
  • 8.3. Contract Research Organizations
  • 8.4. Hospitals & Diagnostic Laboratories
  • 8.5. Pharmaceutical & Biotechnology Companies
  • 8.6. Research Institutes

9. Americas Cell Analysis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Analysis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Analysis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing